![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
Intravenous drug use, which has been recognized as the second most common risk behavior associated with AIDS, was studied among methadone outpatients who were enrolled in a methadone program at a hospital-based clinic in New York City. Intercorrelations among the following variables were observed: sociodemographic, psychological, drug use patterns, and criminal history. Then a stepwise discriminant analysis was employed to examine factors differentiating the high risk clients from the lower risk clients in terms of needle use/sharing in the 30 days prior to the interview. The subjects (N = 152) were heterosexual (95%), non-White (63%), had no more than 12 years of education (72%), were not full-time employed (65%), and had been arrested at least once (79%). The median age at the time of entering the methadone treatment was 33 and the median length of stay in the treatment was 17.5 months (mean = 44.7 months), with an average 52 mg of methadone dosage. Results indicated that risk behavior in terms of current needle use/sharing occurred in about 16% of a sample of clients in the methadone maintenance. A shorter length of stay in treatment was the strongest predictor of high risk, followed by early arrest history, ethnicity, depression, and employment status.